Search

Your search keyword '"Nadeu, Ferran"' showing total 457 results

Search Constraints

Start Over You searched for: Author "Nadeu, Ferran" Remove constraint Author: "Nadeu, Ferran"
457 results on '"Nadeu, Ferran"'

Search Results

1. MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma

2. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma

3. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target

5. Molecular map of chronic lymphocytic leukemia and its impact on outcome

6. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features

8. Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes

10. Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma

11. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

12. Unraveling the genetics of transformed splenic marginal zone lymphoma

13. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

17. Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.

18. Signatures of TOP1 transcription-associated mutagenesis in cancer and germline

19. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features

21. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia

24. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

25. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era

26. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

28. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

30. Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation

31. Evolutionary dynamics of 1,976 lymphoid malignancies predict clinical outcome

32. A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma

33. All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia

35. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration

36. Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline

37. The U1 spliceosomal RNA is recurrently mutated in multiple cancers

38. BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases

39. P600: DNA METHYLATION ANALYSIS OF B-CELL PROLYMPHOCYTIC LEUKEMIA REVEALS TWO EPIGENETIC SUBTYPES WITH DISTINCT BIOLOGICAL AND CLINICAL FEATURES

41. IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

42. Timing the initiation of multiple myeloma

44. A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.

46. A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses

47. Supplementary tables from Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study

48. Supplementary Data from A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma

49. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status:a study by ERIC in HARMONY

50. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

Catalog

Books, media, physical & digital resources